ApprovalTrail

Drug · DIN 02049260

REFRESH PLUS

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since February 21, 2025; first marketed January 31, 2000.
Drug Identification Number (DIN)
02049260
Company (DIN owner)
AbbVie CorporationSaint-Laurent, Quebec, Canada
Schedule
Non-prescription drugs
Dosage form
Drops
Route
Ophthalmic
Therapeutic class (ATC)
Artificial tears and other indifferent preparations. S01XA20
Class
Human
Record last updated
April 24, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
CARBOXYMETHYLCELLULOSE SODIUM0.5 %W/V